John Bartlett

Cited by

	All	Since 2016
Citations	32360	18403
h-index	82	52
i10-index	283	184

6000

3000

1500

4500

19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202190 87 109 129 181 221 301 437 499 573 772 816 1075 1133 1323 1495 1700 2047 2437 2610 3104 4305 5712 168

Co-authors

Joanne EdwardsProfessor of Translational Pathology, University of GlasgowVerified email at glasgow.ac.uk
Christos Markopoulos, Professor of Su...National and Kapodistrian University of Athens, Medical School, Athens, GreeceVerified email at med.uoa.gr
Giuseppe VialeUniversità di Milano e Istituto Europeo di OncologiaVerified email at ieo.it
Going, James J.Consultant Histopathologist, GlasgowVerified email at udcf.gla.ac.uk
Caroline J Witton WarnerResearch Scientist, AgilentVerified email at agilent.com
Hein PutterProfessor of Medical Statistics, Leiden University Medical CenterVerified email at lumc.nl
Torsten NielsenProfessor of Pathology, University of British ColumbiaVerified email at mail.ubc.ca
Tove KirkegaardKirurgisk Afdeling, Køge og Roskilde Sygehus, ForskningskoordinatorVerified email at tovekirkegaard.dk
Antonio C. Wolff, MD, FACP, FASCOProfessor of Oncology, Johns Hopkins UniversityVerified email at jhmi.edu
Kathleen I. PritchardProfessor, Division of Medical Oncology, University of TorontoVerified email at sunnybrook.ca
Peter S HallUniversity of EdinburghVerified email at ed.ac.uk
David G. HicksProfessor of Pathology and Laboratory MedicineVerified email at urmc.rochester.edu
Christopher McCabeExecutive Director and CEO, Institute of Health Economics, AlbertaVerified email at ualberta.ca
Judith BlissProfessor of Clinical Trials, The Institute of Cancer ResearchVerified email at icr.ac.uk
Fatima CardosoBreast Unit, Champalimaud Clinical Center, Lisbon, PortugalVerified email at fundacaochampalimaud.pt
Simon LangdonUniversity of Edinburgh, ReaderVerified email at ed.ac.uk
Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
Emad RakhaUniversity of NottinghamVerified email at nottingham.ac.uk
Liane McGlynnUniversity of Glasgow, Institute of Cancer SciencesVerified email at glasgow.ac.uk
Paul PharoahUniversity of CambridgeVerified email at medschl.cam.ac.uk

John Bartlett

Director of Transformative Pathology, Ontario Institute for Cancer Research

Verified email at oicr.on.ca - Homepage

Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice … AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ... Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2013	3676	2013
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011	1456	2011
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015	1407	2015
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	1065	2018
Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017	914	2017
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	847	2018
A short history of the polymerase chain reaction JMS Bartlett, D Stirling PCR protocols, 3-6, 2003	735	2003
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003	649	2003
Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017	614	2017
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press Journal of Clinical Oncology 27 (8), 1323-1333, 2009	567	2009
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ... Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018	534	2018
An international Ki67 reproducibility study MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ... Journal of the National Cancer Institute, djt306, 2013	463	2013
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of Oncology 25 (8), 1536-1543, 2014	444	2014
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer J Edwards, NS Krishna, KM Grigor, JMS Bartlett British journal of cancer 89 (3), 552-556, 2003	427	2003
Multidisciplinary meeting on male breast cancer: summary and research recommendations LA Korde, JA Zujewski, L Kamin, S Giordano, S Domchek, WF Anderson, ... Journal of Clinical Oncology 28 (12), 2114-2122, 2010	405	2010
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial CJH Van de Velde, D Rea, C Seynaeve, H Putter, A Hasenburg, ... The Lancet 377 (9762), 321-331, 2011	385	2011
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns F Notta, M Chan-Seng-Yue, M Lemire, Y Li, GW Wilson, AA Connor, ... Nature, 2016	312	2016
AKT activation predicts outcome in breast cancer patients treated with tamoxifen T Kirkegaard, CJ Witton, LM McGlynn, SM Tovey, B Dunne, A Lyon, ... The Journal of pathology 207 (2), 139-146, 2005	305	2005
Evaluating HER2 amplification and overexpression in breast cancer J Bartlett, JJ Going, EA Mallon, AD Watters, JR Reeves, P Stanton, ... The Journal of pathology 195 (4), 422-428, 2001	297	2001
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018	276	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Upload PDF

Follow this author

Cited by

Co-authors